|
|
|
01 Sep 2010 |
Concordia Pharmaceuticals, Inc. Signs First Licensing Agreement with Ono Pharmaceutical Co, Ltd. for Salirasib
|
6 |
|
31 Aug 2010 |
BTG plc (BGC.L) Signs $16.6 Mln Deal To Sell Nycomed's Antivenom Drugs
|
10 |
|
27 Aug 2010 |
Basilea announces distribution agreement with Actelion for Toctino(R) in Canada
|
8 |
|
24 Aug 2010 |
Vyteris and Georgia Tech Enter Into Exclusive Agreement for Transdermal Drug Delivery Technologies
|
50 |
|
24 Aug 2010 |
Isotechnika Pharma and 3SBio Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
|
65 |
|
18 Aug 2010 |
Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
|
12 |
|
06 Aug 2010 |
Galapagos Initiates Phase I Study for JAK Inhibitor GLPG0634, Acquires Full Rights to Compound From GSK
|
22 |
|
06 Aug 2010 |
Vectura and GlaxoSmithKline sign agreement to license some of Vectura’s dry powder drug formulation patents
|
28 |
|
05 Aug 2010 |
Depomed Licenses GLUMETZA(R) Data and Acuform(R) Technology
|
19 |
|
04 Aug 2010 |
TapImmune Signs Research and Technology License Option Agreement for Smallpox Vaccine
|
12 |
|
03 Aug 2010 |
Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
|
12 |
|
02 Aug 2010 |
Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
|
15 |
|
02 Aug 2010 |
Osteologix and Servier Announce ex-US Licensing Agreement
|
19 |
|
30 Jul 2010 |
Actient Pharmaceuticals, LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB, INC.
|
14 |
|
29 Jul 2010 |
GSK Exercises Option on Anacor's Novel Antibiotic for the Treatment of Gram-Negative Infections
|
19 |
|
26 Jul 2010 |
NovImmune Enters Exclusive Antibody Licensing Agreement with Genentech
|
15 |
|
15 Jul 2010 |
AMORFIX LIFE SCIENCES ANNOUNCES GLOBAL LICENSING AGREEMENT FOR THE TREATMENT OF ALS WITH BIOGEN IDEC
|
25 |
|
12 Jul 2010 |
Novartis Obtains Licenses to Develop and Commercialise Two Novel Nanobodies(R)
|
30 |
|
12 Jul 2010 |
Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA
|
25 |
|
12 Jul 2010 |
MRC Technology Enters Into an Exclusive License Agreement With Genentech
|
113 |
|
08 Jul 2010 |
Western States Biopharmaceuticals and University of Colorado Announce Exclusive Licensing Agreement for TCISM Targets to Treat Autoimmune Diseases
|
22 |
|
08 Jul 2010 |
Infinity and Intellikine Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma
|
76 |
|
06 Jul 2010 |
Curis Achieves Phase I Milestone Under Hsp90 Collaboration with Debiopharm
|
50 |
|
01 Jul 2010 |
Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval
|
162 |
|
01 Jul 2010 |
GlaxoSmithKline and Genmab announce amendment to Ofatumumab agreement
|
47 |
|
28 Jun 2010 |
Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
|
33 |
|
28 Jun 2010 |
Aestus Therapeutics and Astellas Pharma Sign License Deal for Novel Chronic Pain Therapeutic
|
44 |
|
27 Jun 2010 |
MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program
|
26 |
|
25 Jun 2010 |
Sanofi-aventis and Metabolex enter into an Exclusive Worldwide Licensing Agreement for a Novel Oral Antidiabetic to treat Type II Diabetes
|
169 |
|
25 Jun 2010 |
Bio3 Research s.r.l. Milan Italy exercises an option for exclusive license from Protelica, Hayward, California, for mimic-antibody antagonists to HMGB1
|
127 |
| |
|
Results 1 - 30 of 1172 |
